300 related articles for article (PubMed ID: 28852804)
1. Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor.
Lay AC; Hurcombe JA; Betin VMS; Barrington F; Rollason R; Ni L; Gillam L; Pearson GME; Østergaard MV; Hamidi H; Lennon R; Welsh GI; Coward RJM
Diabetologia; 2017 Nov; 60(11):2299-2311. PubMed ID: 28852804
[TBL] [Abstract][Full Text] [Related]
2. Expression of SHP-1 induced by hyperglycemia prevents insulin actions in podocytes.
Drapeau N; Lizotte F; Denhez B; Guay A; Kennedy CR; Geraldes P
Am J Physiol Endocrinol Metab; 2013 Jun; 304(11):E1188-98. PubMed ID: 23531619
[TBL] [Abstract][Full Text] [Related]
3. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
[No Abstract] [Full Text] [Related]
4. Insulin resistance in glomerular podocytes: Potential mechanisms of induction.
Rogacka D
Arch Biochem Biophys; 2021 Oct; 710():109005. PubMed ID: 34371008
[TBL] [Abstract][Full Text] [Related]
5. IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes.
Lay AC; Hale LJ; Stowell-Connolly H; Pope RJP; Nair V; Ju W; Marquez E; Rollason R; Hurcombe JA; Hayes B; Roberts T; Gillam L; Allington J; Nelson RG; Kretzler M; Holly JMP; Perks CM; McArdle CA; Welsh GI; Coward RJM
Diabetologia; 2021 Jul; 64(7):1690-1702. PubMed ID: 33758952
[TBL] [Abstract][Full Text] [Related]
6. Insulin increases glomerular filtration barrier permeability through PKGIα-dependent mobilization of BKCa channels in cultured rat podocytes.
Piwkowska A; Rogacka D; Audzeyenka I; Kasztan M; Angielski S; Jankowski M
Biochim Biophys Acta; 2015 Aug; 1852(8):1599-609. PubMed ID: 25952906
[TBL] [Abstract][Full Text] [Related]
7. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
8. The human glomerular podocyte is a novel target for insulin action.
Coward RJ; Welsh GI; Yang J; Tasman C; Lennon R; Koziell A; Satchell S; Holman GD; Kerjaschki D; Tavaré JM; Mathieson PW; Saleem MA
Diabetes; 2005 Nov; 54(11):3095-102. PubMed ID: 16249431
[TBL] [Abstract][Full Text] [Related]
9. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
[TBL] [Abstract][Full Text] [Related]
10. Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy.
Lennon R; Pons D; Sabin MA; Wei C; Shield JP; Coward RJ; Tavaré JM; Mathieson PW; Saleem MA; Welsh GI
Nephrol Dial Transplant; 2009 Nov; 24(11):3288-96. PubMed ID: 19556298
[TBL] [Abstract][Full Text] [Related]
11. Increased SHP-1 protein expression by high glucose levels reduces nephrin phosphorylation in podocytes.
Denhez B; Lizotte F; Guimond MO; Jones N; Takano T; Geraldes P
J Biol Chem; 2015 Jan; 290(1):350-8. PubMed ID: 25404734
[TBL] [Abstract][Full Text] [Related]
12. Persistent Insulin Resistance in Podocytes Caused by Epigenetic Changes of SHP-1 in Diabetes.
Lizotte F; Denhez B; Guay A; Gévry N; Côté AM; Geraldes P
Diabetes; 2016 Dec; 65(12):3705-3717. PubMed ID: 27585521
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1.
Huang H; You Y; Lin X; Tang C; Gu X; Huang M; Qin Y; Tan J; Huang F
Cell Physiol Biochem; 2017; 41(1):163-172. PubMed ID: 28214865
[TBL] [Abstract][Full Text] [Related]
14. Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuria.
Jauregui A; Mintz DH; Mundel P; Fornoni A
Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):539-45. PubMed ID: 19724224
[TBL] [Abstract][Full Text] [Related]
15. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F
Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678
[TBL] [Abstract][Full Text] [Related]
16. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway.
Trohatou O; Tsilibary EF; Charonis A; Iatrou C; Drossopoulou G
J Cell Mol Med; 2017 Oct; 21(10):2599-2609. PubMed ID: 28664547
[TBL] [Abstract][Full Text] [Related]
18. High Glucose Impairs Insulin Signaling in the Glomerulus: An In Vitro and Ex Vivo Approach.
Katsoulieris EN; Drossopoulou GI; Kotsopoulou ES; Vlahakos DV; Lianos EA; Tsilibary EC
PLoS One; 2016; 11(7):e0158873. PubMed ID: 27434075
[TBL] [Abstract][Full Text] [Related]
19. Diabetic conditions downregulate the expression of CD2AP in podocytes via PI3-K/Akt signalling.
Ha TS; Hong EJ; Han GD
Diabetes Metab Res Rev; 2015 Jan; 31(1):50-60. PubMed ID: 24846128
[TBL] [Abstract][Full Text] [Related]
20. Podocytes as a target of insulin.
Coward RJ; Saleem MA
Curr Diabetes Rev; 2011 Jan; 7(1):22-7. PubMed ID: 21067503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
